Not provided
| ID | Type | Description | Link |
|---|---|---|---|
| IK2RX002938 | U.S. NIH Grant/Contract | View source | |
| 2023CWR-NDS-831171250 | Other Grant/Funding Number | Cures Within Reach |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
The purpose of this study is to examine safety, feasibility, and the behavioral and brain effects of a non-invasive treatment, repetitive transcranial magnetic stimulation (rTMS), for Veterans with Parkinson's disease or atypical parkinsonism and mild impairments in their thinking. The hypothesis is that rTMS can improve thinking for people with Parkinson's disease or atypical parkinsonism who are experiencing mild problems with their thinking ability.
Repetitive transcranial magnetic stimulation (rTMS) shows promise as an effective cognitive neurorehabilitation treatment. To date, no rTMS studies have assessed the effect of rTMS on cognitive function in PD-MCI. Nor has there been PD neurophysiological studies using rTMS to examine neural plasticity in cognitive neural networks. This study seeks to fill this gap by conducting a small scaled pilot randomized controlled trial (RCT) designed to assess the safety and therapeutic effects of rTMS on cognitive outcomes as well as on brain connectivity in Veterans with PD-MCI. PD-MCI participants will be randomized to either active rTMS or sham rTMS. Participants will complete a standardized neurocognitive battery assessment at baseline, endpoint and at a one month follow-up. The primary outcome is change in executive function. Secondary outcomes include performance on other cognitive domain tasks and a proximal measure of real-life function that captures relevant functional changes related to cognitive impairment in PD. Multi-modal neuroimaging, in a subsample of participants, will be used to study neural connectivity changes induced by rTMS. Changes in resting state functional connectivity, grey matter volume via voxel-based morphometry and white matter integrity via diffusion tensor imaging will be assessed at baseline and endpoint. To inform how to optimize rTMS treatment in PD-MCI, these changes will be correlated with changes in cognitive performance.
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| active rTMS | Experimental | For active rTMS, a butterfly coil and MagVenture MagProX100 stimulator (MagVenture, Falun, Denmark) will be used. One rTMS session will consist of 40 trains of 5sec each at 110% of resting motor threshold and 15Hz will be provided at the left DLPFC. |
|
| sham rTMS | Sham Comparator | For sham rTMS, the procedure will be carried out at the left DLPFC but a sham coil will be used. The MagVenture coil has an active side and a placebo side allowing a double-blind study to be conducted. The sham system looks, sounds and feels like active rTMS. |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| MagVenture MagProX100 stimulator (MagVenture, Falun, Denmark) | Device | The coil will be held tangentially to the skull at approximately 45ยบ from the midline. One rTMS session will consist of 40 trains of 5sec each at 110% of resting motor threshold and 15Hz will be provided at the left DLPFC. |
| Measure | Description | Time Frame |
|---|---|---|
| change in NIH sponsored Executive Abilities: Measures and Instruments for neurobehavioral evaluation and re-search (NIH-EXAMINER) executive composite score | The NIH-EXAMINER has an established 3-factor model defined by (1) cognitive control, (2) working memory (3) fluency. A confirmatory factor analysis indicates these 3-factors load on to 1-factor: executive composite score. Seven tests in the NIH-EXAMINER will be used to compute the composite score | baseline, 8 weeks, 12 weeks |
Not provided
Not provided
Inclusion Criteria:
Exclusion Criteria:
Dementia
Failure to demonstrate decision making capacity
History of deep brain stimulation surgery
Severe depression
Resting head tremor
Dyskinesia that will interfere with collecting imaging data
Has congestive heart failure
Implanted cardiac pacemaker or defibrillator
Cochlear implant, nerve stimulator, or intracranial metal clips
Implanted medical pump
Increased intracranial pressure
History of claustrophobia
Metal in eyes/face, shrapnel/bullet remnants in brain
Participants at potential increased risk of seizure including those who have the following:
history (or family history) of seizure or epilepsy
history of stroke, head injury, or unexplained seizures
presence of other neurological disease that may be associated with an altered seizure threshold
Concurrent medication use such as tricyclic antidepressants, neuroleptic medications, any other drug known to lower seizure threshold
Secondary conditions that may significantly alter electrolyte balance or lower seizure threshold
No quantifiable motor threshold such that rTMS dosage cannot be accurately deter-mined
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Role | Phone | Extension | |
|---|---|---|---|---|
| Sandra L Kletzel, PhD BA | Contact | (708) 202-5735 | Sandra.Kletzel@va.gov | |
| Alexandria N Umbarger, BS | Contact | (708) 998-8213 | alexandria.umbarger@va.gov |
| Name | Affiliation | Role |
|---|---|---|
| Sandra L. Kletzel, PhD BA | Edward Hines Jr. VA Hospital, Hines, IL | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Jesse Brown VA Medical Center, Chicago, IL | Not yet recruiting | Chicago | Illinois | 60612 | United States |
| PubMed Identifier | Type | Citation | Retractions |
|---|---|---|---|
| 42372258 | Derived | Kletzel S, Alsakaji R, Umbarger A, Walker S, Aaronson A, Herrold A, Colletta K, Bhaumik D, Weaver F, Bender Pape T. Repetitive Transcranial Magnetic Stimulation as a Cognitive Rehabilitation Approach for Veterans With Parkinson Disease and Mild Cognitive Impairment: Protocol for a Randomized Sham-Controlled Trial. JMIR Res Protoc. 2026 Jun 29;15:e77241. doi: 10.2196/77241. |
Not provided
Not provided
Raw and/or normalized data will be made available in the form of Excel files. MRI images will anonymized and made available through the Northwestern University Neuroimaging Data Archive (NUNDA).
Not provided
Final data sets will be made available as per Hines VA Hospital local policy for long term storage and access until enterprise-level resources become available.
These data will be available upon request by researchers and scientists in accordance with federal guidelines and Hines local policy.
Not provided
Not provided
| ID | Term |
|---|---|
| D010300 | Parkinson Disease |
| D060825 | Cognitive Dysfunction |
| ID | Term |
|---|---|
| D020734 | Parkinsonian Disorders |
| D001480 | Basal Ganglia Diseases |
| D001927 | Brain Diseases |
| D002493 | Central Nervous System Diseases |
Not provided
Not provided
randomized control trial. Participants will receive either active or sham rTMS
Not provided
Not provided
Not provided
|
| MagVenture MagProX100 stimulator (MagVenture, Falun, Denmark) | Device | The coil will be held tangentially to the skull at approximately 45ยบ from the midline. The sham coil will not release any stimulation, but it will look, feel and sound like the real rTMS |
|
| Edward Hines Jr. VA Hospital, Hines, IL | Recruiting | Hines | Illinois | 60141-3030 | United States |
|
| D009422 | Nervous System Diseases |
| D009069 | Movement Disorders |
| D000080874 | Synucleinopathies |
| D019636 | Neurodegenerative Diseases |
| D003072 | Cognition Disorders |
| D019965 | Neurocognitive Disorders |
| D001523 | Mental Disorders |